Volume 20 Issue 9
Sep.  2022
Turn off MathJax
Article Contents
NIU Kai-xuan, WU Shu-lu, LIU Cheng, DENG Xi-ming. Clinical value of serum amyloid A and interleukin-6 in the diagnosis and severity evaluation of sepsis[J]. Chinese Journal of General Practice, 2022, 20(9): 1484-1487. doi: 10.16766/j.cnki.issn.1674-4152.002629
Citation: NIU Kai-xuan, WU Shu-lu, LIU Cheng, DENG Xi-ming. Clinical value of serum amyloid A and interleukin-6 in the diagnosis and severity evaluation of sepsis[J]. Chinese Journal of General Practice, 2022, 20(9): 1484-1487. doi: 10.16766/j.cnki.issn.1674-4152.002629

Clinical value of serum amyloid A and interleukin-6 in the diagnosis and severity evaluation of sepsis

doi: 10.16766/j.cnki.issn.1674-4152.002629
Funds:

 2019-54

 KJ2019A0351

  • Received Date: 2022-04-05
    Available Online: 2022-11-29
  •   Objective  To explore the significance of serum amyloid A (SAA) and interleukin-6 (IL-6) in the diagnosis and severity evaluation of sepsis.  Methods  A total of 80 patients in the Department of Critical Care Medicine of the First Affiliated Hospital of Bengbu Medical College from October 1, 2020 to May 31, 2021 were selected, and scores of SAA, IL-6, procalcitonin (PCT), C-reactive protein (CRP), APACHE Ⅱ and SOFA were collected within 24 hours from admission. According to the diagnostic criteria of sepsis, 25 cases were divided into the non-sepsis group and 55 cases were divided into the sepsis group. The diagnostic efficacy of SAA and IL-6 in sepsis was evaluated by ROC curve, while the correlation between SAA, IL-6 and APACHE Ⅱ score, SOFA score was explored by Spearman analysis. According to the diagnostic criteria of septic shock, patients with sepsis were divided into the common sepsis group (n=25) and the septic shock group (n=30), and the judgment value of SAA and IL-6 on the severity of the disease was evaluated.  Results  The ROC curve for the diagnosis of sepsis showed high sensitivity and specificity of IL-6 (94.4%, 63.4%). SAA combined with PCT had the highest specificity (95.8%). IL-6 combined with CRP had the highest sensitivity (100.0%). SAA and IL-6 were positively correlated with APACHE Ⅱ score and SOFA score. The ROC results to assess the severity of the disease showed that the specificity of SAA alone and IL-6 combined with PCT was the highest (both 80.0%), and the sensitivity of SAA combined with PCT was the highest (96.0%).  Conclusion  SAA and IL-6 can be used as effective markers to evaluate the severity of sepsis, and IL-6 can also assist in the early diagnosis of sepsis. The combination of SAA and IL-6 with PCT and CRP can improve the clinical value.

     

  • loading
  • [1]
    TAN M C, LU Y X, JIANG H, et al. The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: A systematic review and meta-analysis[J]. J Cell Biochem, 2019, 120(4): 5852-5859. doi: 10.1002/jcb.27870
    [2]
    HUANG M, CAI S L, SU J Q. The pathogenesis of sepsis and potential therapeutic targets[J]. Int J Mol Sci, 2019, 20(21): 5376. doi: 10.3390/ijms20215376
    [3]
    中国中西医结合学会检验医学专业委员会. 血清淀粉样蛋白A在感染性疾病中临床应用的专家共识[J]. 中华检验医学杂志, 2019, 42(3): 186-192.

    Laboratory Medicine Committee of Chinese Association of Integrated Traditional Chinese and Western Medicine. Expert consensus on clinical application of serum amyloid A in infectious diseases[J]. Chinese Journal of Laboratory Medicine, 2019, 42(3): 186-192.
    [4]
    HU P Y, CHEN Y L, PANG J M, et al. Association between IL-6 polymorphisms and sepsis[J]. Innate Immun, 2019, 25(8): 465-472. doi: 10.1177/1753425919872818
    [5]
    孙晓琪, 刘贤英, 陈颖, 等. 血清降钙素原在脓毒症临床诊断中的应用研究[J]. 中华医院感染学杂志, 2019, 29(14): 2095-2098. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201914006.htm

    SUN X Q, LIU X Y, CHEN Y, et al. Clinical value of serum procalcitonin in diagnosis of sepsis[J]. Chinese Journal of Nosocomiology, 2019, 29(14): 2095-2098. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201914006.htm
    [6]
    SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. doi: 10.1001/jama.2016.0287
    [7]
    RUDD K E, JOHNSON S C, AGESA K M, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 395(10219): 200-211. doi: 10.1016/S0140-6736(19)32989-7
    [8]
    QU J Y, FENG P, LUO Y, et al. Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease: A retrospective analysis of 324 cases[J]. Medicine (Baltimore), 2016, 95(30): e4270. DOI: 10.1097/MD.0000000000004270.
    [9]
    TRENCHEVSKA O, YASSINE H N, BORGES C R, et al. Development of quantitative mass spectrometric immunoassay for serum amyloid A[J]. Biomarkers, 2016, 21(8): 743-751. doi: 10.1080/1354750X.2016.1201533
    [10]
    曹琳, 宋晓文, 任金来, 等. 血清淀粉样蛋白A的研究进展[J]. 安徽医药, 2019, 23(2): 221-224. https://www.cnki.com.cn/Article/CJFDTOTAL-AHYY201902004.htm

    CAO L, SONG X W, REN J L, et al. Advances in research into serum amyloid A[J]. Anhui Medical and Pharmaceutical Journal, 2019, 23(2): 221-224. https://www.cnki.com.cn/Article/CJFDTOTAL-AHYY201902004.htm
    [11]
    DE BUCK M, GOUWY M, WANG J M, et al. Structure and expression of different serum amyloid A (SAA) vari-ants and their concentration-dependent functions during host insults[J]. Curr Med Chem, 2016, 23(17): 1725-1755. doi: 10.2174/0929867323666160418114600
    [12]
    ROSE-JOHN S. Interleukin-6 family cytokines[J]. Cold Spring Harb Perspect Biol, 2018, 10(2): a028415. DOI: 10.1101/cshperspect.a028415.
    [13]
    SONG J, PARK D W, MOON S, et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: A prospective controlled study according to the Sepsis-3 definitions[J]. BMC Infect Dis, 2019, 19(1): 968. doi: 10.1186/s12879-019-4618-7
    [14]
    HOU T Y, HUANG D H, ZENG R, et al. Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: A systematic review and meta-analysis[J]. Int J Clin Exp Med, 2015, 8(9): 15238-15245.
    [15]
    宫榭阳, 徐鹏, 葛长宇, 等. IL-6在卵巢癌中的研究进展[J]. 中华全科医学, 2019, 17(3): 455-458. doi: 10.16766/j.cnki.issn.1674-4152.000707

    GONG X Y, XU P, GE C Y, et al. Research progress on IL-6 in ovarian cancer[J]. Chinese Journal of General Practice, 2019, 17(3): 455-458. doi: 10.16766/j.cnki.issn.1674-4152.000707
    [16]
    PIERRAKOS C, VINCENT J L. Sepsis biomarkers: A review[J]. Crit Care, 2010, 14(1): R15. DOI: 10.1186/cc8872.
    [17]
    PIERRAKOS C, VELISSARIS D, BISDORFF M, et al. Biomarkers of sepsis: Time for a reappraisal[J]. Crit Care, 2020, 24(1): 287. doi: 10.1186/s13054-020-02993-5
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(5)

    Article Metrics

    Article views (344) PDF downloads(10) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return